Cargando…
RF21 | PSAT99 Urinary adrenal steroidome modifications by Ketoconazole and Metyrapone alter the urinary free cortisol immunoassay reliability in Cushing Syndrome
INTRODUCTION: Twenty-four-hour urinary free cortisol (24h-UFC) is the most used test for follow-up decision-making in patients with Cushing syndrome (CS) under adrenal-directed medical treatment. In CS patients without medical treatment, 24h-UFC determinations by immunoassays (IA) are commonly overe...
Autores principales: | Vega-Beyhart, Arturo, Fellow, Predoctoral, Laguna-Moreno, Javier, Díaz-Catalãn, Daniela, Boswell, Laura, Mora, Mireia, Halperin, Irene, Casals, Gregori, Hanzu, Felicia A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624925/ http://dx.doi.org/10.1210/jendso/bvac150.282 |
Ejemplares similares
-
Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome
por: Vega-Beyhart, Arturo, et al.
Publicado: (2022) -
OR03-05 Novel Lipidome Signature in Active Cushing Syndrome Revealed by UHPLC-MS Metabolomics
por: Vega-Beyhart, Arturo, et al.
Publicado: (2020) -
Adrenal Cushing’s in Pregnancy, Managed with Metyrapone to Optimize for Adrenalectomy at 27 Weeks Gestation
por: Shah, Leena, et al.
Publicado: (2021) -
SUN-LB068 Ectopic Cushing Syndrome Due to a Metastatic Neuroendocrine Tumor Treated with Metyrapone
por: Tsomos, Effie, et al.
Publicado: (2019) -
Cortisol Measurements in Cushing's Syndrome: Immunoassay or Mass Spectrometry?
por: Casals, Gregori, et al.
Publicado: (2020)